Global Pharmaceuticals & Biotech Breakout Stocks

Pharmaron Beijing

Market Cap: CN¥82.9b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$65.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

10x Genomics

Market Cap: US$7.5b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Genscript Biotech

Market Cap: HK$56.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

MGI Tech

Market Cap: CN¥29.0b

Engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

AbCellera Biologics

Market Cap: US$3.4b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Harbin Pharmaceutical Group

Market Cap: CN¥22.3b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

Shanghai Haoyuan Chemexpress

Market Cap: CN¥21.1b

Engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.

GemPharmatech

Market Cap: CN¥16.7b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

HitGen

Market Cap: CN¥16.0b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

AcrobiosystemsLtd

Market Cap: CN¥14.7b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Sino BiologicalInc

Market Cap: CN¥14.6b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

Shanghai Medicilon

Market Cap: CN¥14.1b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

Shanghai InnoStar Bio-tech

Market Cap: CN¥13.4b

Provides drug research and development services in China and internationally.

Lin BioScience

Market Cap: NT$62.8b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

PharmaBlock Sciences (Nanjing)

Market Cap: CN¥12.8b

Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.

Nanjing Vazyme Biotech

Market Cap: CN¥12.6b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

HBM Holdings

Market Cap: HK$13.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥9.5b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

Shanghai OPM Biosciences

Market Cap: CN¥9.4b

Provides cell culture media and CDMO services in China and internationally.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥8.2b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Bide Pharmatech

Market Cap: CN¥7.3b

Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.

PharmaResources (Shanghai)

Market Cap: CN¥7.0b

Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.

Omeros

Market Cap: US$992.3m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Novogene

Market Cap: CN¥6.7b

Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.

R&G PharmaStudies

Market Cap: CN¥6.1b

Operates as a clinical trial outsourcing service provider in China and internationally.

GlaxoSmithKlineE

Market Cap: ج.م43.5b

Engages in production of pharmaceutical chemicals.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥5.7b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

Aarti Pharmalabs

Market Cap: ₹79.2b

Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥5.6b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Boji Medical TechnologyLtd

Market Cap: CN¥5.5b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Sichuan Goldstone Asia Pharmaceutical

Market Cap: CN¥5.2b

Sichuan Goldstone Asia Pharmaceutical Inc.

Novoprotein Scientific

Market Cap: CN¥4.5b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

Oncolys BioPharma

Market Cap: JP¥98.7b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

OmniAb

Market Cap: US$497.2m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Shanghai Kai Kai Industry

Market Cap: CN¥3.2b

Engages in the wholesale and retail of pharmaceutical products in China.